350.2 𩺠åèç
350.2.1 é«é »èé»
350.2.1.1 IBS Rome IV
- ⥠1 day/week abdominal pain à 3 months
- 2+ of: defecation-related, stool frequency change, stool form change
- Subtypes: D, C, M, U
350.2.1.2 Alarm Features (Workup)
- ⥠50 yo new onset
- Weight loss
- Hematochezia
- Anemia
- Family history GI cancer
- Nocturnal symptoms
350.2.1.4 Pathophysiology Multifactorial
- Visceral hypersensitivity
- Altered motility
- Altered microbiome
- Low-grade inflammation
- Brain-gut axis
- Psychosocial
- Post-infectious
350.2.1.5 Treatment IBS-C
- PEG (laxative)
- Linaclotide (Linzess, GC-C)
- Lubiprostone (Amitiza, ClC-2)
- Plecanatide (Trulance, GC-C)
- Tenapanor (Ibsrela, NHE3 inhibitor)
- Prucalopride (Motegrity, 5-HT4 agonist)
350.2.1.6 Treatment IBS-D
- Loperamide (symptomatic)
- Rifaximin (Xifaxan, 14-day course)
- Eluxadoline (Viberzi, avoid pancreatitis/cholecystectomy history)
- Alosetron (Lotronex, women, REMS)
- Bile acid sequestrants if bile acid diarrhea
350.2.1.7 Pain Management
- TCAs (amitriptyline 10-25 HS) â IBS-D especially
- SSRIs â IBS-C especially
- Antispasmodics (dicyclomine, hyoscyamine)
- Peppermint oil
- Pregabalin/gabapentin (off-label)
350.2.1.10 Functional Constipation Subtypes
- Slow transit
- Outlet dysfunction (pelvic floor dyssynergia)
- Normal transit
350.2.2 ææ··æ·æ¯èŒ
| Disorder | Key Feature | Treatment |
|---|---|---|
| IBS | Rome IV pain + bowel | Diet + medication by subtype |
| Functional dyspepsia | Upper GI symptoms | Per Ch348 |
| Functional constipation | Insufficient for IBS | Laxatives, prucalopride |
| Functional diarrhea | No pain | Per cause |
| CVS | Stereotyped episodes | Amitriptyline preventive |
| CHS | Cannabis + hot showers | Cessation |
| Globus | Lump sensation | Reassurance, PPI |